Funding provided by TerSera Therapeutics LLC. Content independently developed by OncLive.
Ovarian Suppression with GnRH Agonists Can Aid Fertility Preservation in Breast Cancer
May 12th 2022Treatment regimens that include ovarian suppression with a gonadotropin-releasing hormone agonist have gained momentum in recent years as a potential solution to address treatment-related early menopause for women with breast cancer.